KIF20A and familial pancreatic carcinoma: For instance, Shingo Asahara et al. demonstrated the significant efficacy and safety of a KIF20A-66 peptide vaccine in advanced pancreatic cancer, pointing towards a paradigm shift in treating this lethal disease [92].